Once-a-week insulin launched in India, but doctors say it won't replace daily shots for all

India now offers Awiqli, a new once-weekly basal insulin for diabetes patients. This drug reduces annual injections from 365 to just 52 for many individuals. Experts suggest Awiqli is an additional option, not a complete replacement for daily insulin. It is best suited for patients who still produce some insulin naturally. This innovation aims to improve treatment adherence and manage blood sugar levels effectively.

Raccontata daeconomictimes.indiatimes.comthehindubusinessline.comhindustantimes.comnewsbytesapp.comthehindu.com